Log in to save to my catalogue

A Case Series and Literature Review on Zanubrutinib Therapy for the Treatment of Relapsed/Refractory...

A Case Series and Literature Review on Zanubrutinib Therapy for the Treatment of Relapsed/Refractory...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3173afb3671c4096881796121611d903

A Case Series and Literature Review on Zanubrutinib Therapy for the Treatment of Relapsed/Refractory Immune Thrombocytopenia

About this item

Full title

A Case Series and Literature Review on Zanubrutinib Therapy for the Treatment of Relapsed/Refractory Immune Thrombocytopenia

Publisher

United States: John Wiley and Sons Inc

Journal title

Cancer reports, 2025-02, Vol.8 (2), p.e70152-n/a

Language

English

Formats

Publication information

Publisher

United States: John Wiley and Sons Inc

More information

Scope and Contents

Contents

ABSTRACT
Background
Immune thrombocytopenia (ITP) is an acquired autoimmune disease characterised by low platelet count. Treatment discontinuation or heterogeneity in the pathogenesis of ITP heightens the occurrence of relapsed or refractory ITP. Bruton's tyrosine kinase (BTK) has emerged as a promising target for autoimmune disorders.
Cas...

Alternative Titles

Full title

A Case Series and Literature Review on Zanubrutinib Therapy for the Treatment of Relapsed/Refractory Immune Thrombocytopenia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3173afb3671c4096881796121611d903

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3173afb3671c4096881796121611d903

Other Identifiers

ISSN

2573-8348

E-ISSN

2573-8348

DOI

10.1002/cnr2.70152

How to access this item